Health Care & Hospital Law,
Civil Litigation
May 25, 2021
State witness says drugmakers paid for positive opioid studies
Endo Pharmaceuticals’ attorney, Moez Kaba of Hueston Hennigan LLP, said it is standard practice for companies seeking Food and Drug Administration approval to fund a study inquiring into the effectiveness of their own products.
Drugmakers paid researchers and funded studies that said opioids were effective for treating long-term pain and were rarely addicting, a witness testified Monday in a $50 billion false advertising bench trial in Orange County.
Testifying via Zoom, Dr. Anna Lembke of Stanford School of Medicine, a key witness for the state, said Endo Pharmaceuticals, which along with other drugmakers is accused of contributing to the state's opioid c...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
Enewsletter Sign-up
Related Content
Health Care & Hospital Law, Civil Litigation
Plaintiffs close false advertising case against drugmakers
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Judge denies many untimely filed plaintiffs’ documents in opioid trial
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Allergan says there’s no false advertising if public never sees it
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
State’s expert admits bias against opioids
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Quarter of patients addicted after opioid pain prescription, doctor testifies
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Opioid makers hyped products while downplaying risks, expert testifies
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Expert says California in midst of opioid crisis
By Blaise Scemama
Civil Litigation
State expert’s data questioned by defense in Orange County opioid trial
By Blaise Scemama
